Teva Pharmaceutical Industries (TEVA) Intangibles (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded Intangibles of $3.45 billion in Q2 2026, down 16.8% from $4.14 billion a year earlier and down 4.5% from the prior quarter.
Teva Pharmaceutical Industries (TEVA) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Teva Pharmaceutical Industries reported Intangibles of $3.78 billion, down 14.4% from FY2024.
- Annual Intangibles has declined for nine straight years, with a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- Across earlier years, Intangibles came in at $4.42 billion in FY2024 (-18.0%), $5.39 billion in FY2023 (-14.1%), $6.27 billion in FY2022 (-16.0%) and $7.47 billion in FY2021 (-16.3%).
- The Q2 2026 figure is the lowest quarterly Intangibles in data going back to Q1 2009.
- On a year-over-year basis, Intangibles has declined for 36 consecutive quarters, with an average decline of 15.7% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 13.6% (Q3 2023) and 18.4% (Q3 2022) over the last five years.
- Per Business Quant, the preceding three quarters came in at $3.61 billion (Q1 2026), $3.78 billion (Q4 2025) and $3.94 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Teva Pharmaceutical Industries | 46.38 Bn | 33.23 Bn | 2.15 Bn | 3.45 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.45 Bn |
| Mar 31, 2026 | 3.61 Bn |
| Dec 31, 2025 | 3.78 Bn |
| Sep 30, 2025 | 3.94 Bn |
| Jun 30, 2025 | 4.14 Bn |
| Mar 31, 2025 | 4.19 Bn |
| Dec 31, 2024 | 4.42 Bn |
| Sep 30, 2024 | 4.76 Bn |
| Jun 30, 2024 | 4.85 Bn |
| Mar 31, 2024 | 5.06 Bn |
| Dec 31, 2023 | 5.39 Bn |
| Sep 30, 2023 | 5.53 Bn |
| Jun 30, 2023 | 5.74 Bn |
| Mar 31, 2023 | 5.96 Bn |
| Dec 31, 2022 | 6.27 Bn |
| Sep 30, 2022 | 6.39 Bn |
| Jun 30, 2022 | 6.70 Bn |
| Mar 31, 2022 | 7.12 Bn |
| Dec 31, 2021 | 7.47 Bn |
| Sep 30, 2021 | 7.83 Bn |
Teva Pharmaceutical Industries Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=TEVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();